Treated HCC patients without active/residual tumor cells had higher mRNA expression levels of antitumor cytokines, including IFN-γ, TNF-α, and IL-17 when compared with untreated HCC patients (p = 0.016; p = 0.041; p = 0.0146). The gene discussed is IL17A; the disease is hepatocellular carcinoma.